[{"address1": "6001 Oak Canyon", "address2": "Suite 100", "city": "Irvine", "state": "CA", "zip": "92618", "country": "United States", "phone": "877 923 4747", "website": "https://www.inarimedical.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.", "fullTimeEmployees": 1300, "companyOfficers": [{"maxAge": 1, "name": "Mr. Andrew J. Hykes", "age": 51, "title": "CEO, President & Director", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 1539133, "exercisedValue": 0, "unexercisedValue": 12525073}, {"maxAge": 1, "name": "Dr. Thomas M. Tu M.D.", "age": 51, "title": "Chief Medical Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 865633, "exercisedValue": 1166430, "unexercisedValue": 9240177}, {"maxAge": 1, "name": "Mr. Paul A. Koehn", "age": 61, "title": "Senior Vice President of Operations", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Karen  Silva", "title": "Vice President of Finance & Accounting", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Khairy", "title": "Senior Vice President of Marketing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tara  Dunn", "title": "Senior VP & GM of LimFlow", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Shon  Chakrabarti M.D., M.P.H.", "title": "Chief Medical Officer of LimFlow", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 6, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 6, "governanceEpochDate": 1735689600, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 65.0, "open": 78.98, "dayLow": 78.9, "dayHigh": 79.48, "regularMarketPreviousClose": 65.0, "regularMarketOpen": 78.98, "regularMarketDayLow": 78.9, "regularMarketDayHigh": 79.48, "beta": 0.963, "forwardPE": 303.4165, "volume": 15822862, "regularMarketVolume": 15822862, "averageVolume": 1140320, "averageVolume10days": 2052090, "averageDailyVolume10Day": 2052090, "bid": 79.31, "ask": 79.39, "bidSize": 100, "askSize": 100, "marketCap": 4649656832, "fiftyTwoWeekLow": 36.73, "fiftyTwoWeekHigh": 79.48, "priceToSalesTrailing12Months": 8.093426, "fiftyDayAverage": 51.7328, "twoHundredDayAverage": 47.25565, "currency": "USD", "enterpriseValue": 3726556160, "profitMargins": -0.13678001, "floatShares": 53368269, "sharesOutstanding": 58544200, "sharesShort": 3658914, "sharesShortPriorMonth": 3416412, "sharesShortPreviousMonthDate": 1731628800, "dateShortInterest": 1734048000, "sharesPercentSharesOut": 0.0625, "heldPercentInsiders": 0.08527, "heldPercentInstitutions": 0.96531, "shortRatio": 4.02, "shortPercentOfFloat": 0.079, "impliedSharesOutstanding": 58563600, "bookValue": 7.44, "priceToBook": 10.6713705, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -78582000, "trailingEps": -1.35, "forwardEps": 0.14, "enterpriseToRevenue": 6.487, "enterpriseToEbitda": -142.605, "52WeekChange": 0.10188162, "SandP52WeekChange": 0.25625563, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "NARI", "underlyingSymbol": "NARI", "shortName": "Inari Medical, Inc.", "longName": "Inari Medical, Inc.", "firstTradeDateEpochUtc": 1590154200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "6b5f2d67-f3ad-36ce-983b-18a07f1d5dca", "messageBoardId": "finmb_140993984", "gmtOffSetMilliseconds": -18000000, "currentPrice": 79.395, "targetHighPrice": 86.0, "targetLowPrice": 50.0, "targetMeanPrice": 72.70769, "targetMedianPrice": 75.0, "recommendationMean": 1.75, "recommendationKey": "buy", "numberOfAnalystOpinions": 13, "totalCash": 111538000, "totalCashPerShare": 1.905, "ebitda": -26132000, "totalDebt": 32724000, "quickRatio": 1.317, "currentRatio": 1.77, "totalRevenue": 574497984, "debtToEquity": 7.527, "revenuePerShare": 9.901, "returnOnAssets": -0.03212, "returnOnEquity": -0.17721, "freeCashflow": 86606872, "operatingCashflow": 14178000, "revenueGrowth": 0.214, "grossMargins": 0.86817, "ebitdaMargins": -0.045489997, "operatingMargins": -0.04343, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-01-07"}]